Moderna has said up to 1.7bn people at high risk from Covid-19 would benefit from annual booster shots, as it prioritises developing a new jab targeting the fast-spreading Omicron variant to be released in the autumn.
莫德纳(Moderna)表示，多达17亿新冠高危人群将受益于每年的加强针接种，该公司正优先开发一种针对快速传播的Omicron变种的新疫苗，将于秋季发布。
您已阅读6%（294字），剩余94%（4679字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。